NCT03310710View on ClinicalTrials.gov

VIABAHN BX Used in Fenestrated EVAR Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

October 17, 2018

Study Completion Date

November 1, 2019

Conditions
Aortic Aneurysm, Abdominal
Interventions
DEVICE

Viabahn BX stent

Viabahn BX stent graft used as the branch device with a fenestrated EVAR graft

Trial Locations (1)

M5G 2N2

University Health Network, Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03310710 - VIABAHN BX Used in Fenestrated EVAR Study | Biotech Hunter | Biotech Hunter